SRF Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 21, 2025, 7:28 am

Quick Insight

SRF Ltd, a prominent player in the Chemicals – Others sector, currently trades at a price of 2,846 with a market capitalization of 84,412 Cr. Despite a high P/E ratio of 59.0, the company shows a respectable ROE of 10.4% and ROCE of 12.3%. With an OPM of 22%, SRF Ltd has generated a net profit of 1,251 Cr. The company's strong financial position is evident from its reserves of 12,329 Cr and low borrowings of ₹4,726 Cr, resulting in a healthy ICR of 7.58x. However, investors should note the relatively high P/BV ratio of 6.92x. Overall, SRF Ltd presents a solid investment opportunity given its robust financial performance and market position, but caution is advised due to its elevated valuation multiples.

Competitors of SRF Ltd

All Competitor Stocks of SRF Ltd

Quarterly Result

Last Updated: August 1, 2025, 11:10 am

Below is a detailed analysis of the quarterly data for SRF Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 3,819.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,313.00 Cr. (Mar 2025) to 3,819.00 Cr., marking a decrease of 494.00 Cr..
• For Expenses, as of Jun 2025, the value is 2,989.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3,356.00 Cr. (Mar 2025) to 2,989.00 Cr., marking a decrease of 367.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 830.00 Cr.. The value appears to be declining and may need further review. It has decreased from 957.00 Cr. (Mar 2025) to 830.00 Cr., marking a decrease of 127.00 Cr..
• For OPM %, as of Jun 2025, the value is 22.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 22.00%.
• For Other Income, as of Jun 2025, the value is 29.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2025) to 29.00 Cr., marking a decrease of 5.00 Cr..
• For Interest, as of Jun 2025, the value is 80.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 89.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 9.00 Cr..
• For Depreciation, as of Jun 2025, the value is 203.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 195.00 Cr. (Mar 2025) to 203.00 Cr., marking an increase of 8.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 576.00 Cr.. The value appears to be declining and may need further review. It has decreased from 707.00 Cr. (Mar 2025) to 576.00 Cr., marking a decrease of 131.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Mar 2025) to 25.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 432.00 Cr.. The value appears to be declining and may need further review. It has decreased from 526.00 Cr. (Mar 2025) to 432.00 Cr., marking a decrease of 94.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 14.58. The value appears to be declining and may need further review. It has decreased from 17.75 (Mar 2025) to 14.58, marking a decrease of 3.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:11 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 11:18 am

Below is a detailed analysis of the balance sheet data for SRF Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 297.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 297.00 Cr..
• For Reserves, as of Mar 2025, the value is 12,329.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,182.00 Cr. (Mar 2024) to 12,329.00 Cr., marking an increase of 1,147.00 Cr..
• For Borrowings, as of Mar 2025, the value is 4,726.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5,031.00 Cr. (Mar 2024) to 4,726.00 Cr., marking a decrease of 305.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 4,169.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,945.00 Cr. (Mar 2024) to 4,169.00 Cr., marking an increase of 224.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 21,521.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 20,454.00 Cr. (Mar 2024) to 21,521.00 Cr., marking an increase of 1,067.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 13,720.00 Cr.. The value appears strong and on an upward trend. It has increased from 13,242.00 Cr. (Mar 2024) to 13,720.00 Cr., marking an increase of 478.00 Cr..
• For CWIP, as of Mar 2025, the value is 811.00 Cr.. The value appears strong and on an upward trend. It has increased from 805.00 Cr. (Mar 2024) to 811.00 Cr., marking an increase of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 827.00 Cr.. The value appears strong and on an upward trend. It has increased from 527.00 Cr. (Mar 2024) to 827.00 Cr., marking an increase of 300.00 Cr..
• For Other Assets, as of Mar 2025, the value is 6,163.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,881.00 Cr. (Mar 2024) to 6,163.00 Cr., marking an increase of 282.00 Cr..
• For Total Assets, as of Mar 2025, the value is 21,521.00 Cr.. The value appears strong and on an upward trend. It has increased from 20,454.00 Cr. (Mar 2024) to 21,521.00 Cr., marking an increase of 1,067.00 Cr..

Notably, the Reserves (12,329.00 Cr.) exceed the Borrowings (4,726.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for SRF Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 42.20. This value is within the healthy range. It has decreased from 45.06 (Mar 24) to 42.20, marking a decrease of 2.86.
• For Diluted EPS (Rs.), as of Mar 25, the value is 42.20. This value is within the healthy range. It has decreased from 45.06 (Mar 24) to 42.20, marking a decrease of 2.86.
• For Cash EPS (Rs.), as of Mar 25, the value is 67.99. This value is within the healthy range. It has increased from 67.52 (Mar 24) to 67.99, marking an increase of 0.47.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 424.50. It has increased from 385.93 (Mar 24) to 424.50, marking an increase of 38.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 424.50. It has increased from 385.93 (Mar 24) to 424.50, marking an increase of 38.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 493.98. It has increased from 441.72 (Mar 24) to 493.98, marking an increase of 52.26.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 95.86. This value is within the healthy range. It has increased from 89.67 (Mar 24) to 95.86, marking an increase of 6.19.
• For PBIT / Share (Rs.), as of Mar 25, the value is 69.92. This value is within the healthy range. It has increased from 67.06 (Mar 24) to 69.92, marking an increase of 2.86.
• For PBT / Share (Rs.), as of Mar 25, the value is 57.28. This value is within the healthy range. It has increased from 56.89 (Mar 24) to 57.28, marking an increase of 0.39.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 42.05. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 42.05, marking a decrease of 2.86.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 42.05. This value is within the healthy range. It has decreased from 44.91 (Mar 24) to 42.05, marking a decrease of 2.86.
• For PBDIT Margin (%), as of Mar 25, the value is 19.40. This value is within the healthy range. It has decreased from 20.30 (Mar 24) to 19.40, marking a decrease of 0.90.
• For PBIT Margin (%), as of Mar 25, the value is 14.15. This value is within the healthy range. It has decreased from 15.18 (Mar 24) to 14.15, marking a decrease of 1.03.
• For PBT Margin (%), as of Mar 25, the value is 11.59. This value is within the healthy range. It has decreased from 12.87 (Mar 24) to 11.59, marking a decrease of 1.28.
• For Net Profit Margin (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has decreased from 10.16 (Mar 24) to 8.51, marking a decrease of 1.65.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has decreased from 10.16 (Mar 24) to 8.51, marking a decrease of 1.65.
• For Return on Networth / Equity (%), as of Mar 25, the value is 9.90. This value is below the healthy minimum of 15. It has decreased from 11.63 (Mar 24) to 9.90, marking a decrease of 1.73.
• For Return on Capital Employeed (%), as of Mar 25, the value is 12.89. This value is within the healthy range. It has decreased from 13.29 (Mar 24) to 12.89, marking a decrease of 0.40.
• For Return On Assets (%), as of Mar 25, the value is 5.80. This value is within the healthy range. It has decreased from 6.52 (Mar 24) to 5.80, marking a decrease of 0.72.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.15. This value is below the healthy minimum of 0.2. It has decreased from 0.19 (Mar 24) to 0.15, marking a decrease of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 0.42 (Mar 24) to 0.36, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.69. It has increased from 0.66 (Mar 24) to 0.69, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 25, the value is 1.13. This value is below the healthy minimum of 1.5. It has increased from 1.03 (Mar 24) to 1.13, marking an increase of 0.10.
• For Quick Ratio (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has increased from 0.60 (Mar 24) to 0.69, marking an increase of 0.09.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.24. This value is below the healthy minimum of 4. It has increased from 2.91 (Mar 24) to 3.24, marking an increase of 0.33.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 17.06. This value is below the healthy minimum of 20. It has increased from 15.97 (Mar 24) to 17.06, marking an increase of 1.09.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.55. This value is below the healthy minimum of 20. It has decreased from 10.62 (Mar 24) to 10.55, marking a decrease of 0.07.
• For Earning Retention Ratio (%), as of Mar 25, the value is 82.94. This value exceeds the healthy maximum of 70. It has decreased from 84.03 (Mar 24) to 82.94, marking a decrease of 1.09.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.45. This value exceeds the healthy maximum of 70. It has increased from 89.38 (Mar 24) to 89.45, marking an increase of 0.07.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 7.58. This value is within the healthy range. It has decreased from 8.82 (Mar 24) to 7.58, marking a decrease of 1.24.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.33. This value is within the healthy range. It has decreased from 5.42 (Mar 24) to 4.33, marking a decrease of 1.09.
• For Enterprise Value (Cr.), as of Mar 25, the value is 91,715.52. It has increased from 80,584.47 (Mar 24) to 91,715.52, marking an increase of 11,131.05.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.24. This value exceeds the healthy maximum of 3. It has increased from 6.13 (Mar 24) to 6.24, marking an increase of 0.11.
• For EV / EBITDA (X), as of Mar 25, the value is 32.17. This value exceeds the healthy maximum of 15. It has increased from 30.21 (Mar 24) to 32.17, marking an increase of 1.96.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has increased from 5.79 (Mar 24) to 5.95, marking an increase of 0.16.
• For Retention Ratios (%), as of Mar 25, the value is 82.93. This value exceeds the healthy maximum of 70. It has decreased from 84.02 (Mar 24) to 82.93, marking a decrease of 1.09.
• For Price / BV (X), as of Mar 25, the value is 6.92. This value exceeds the healthy maximum of 3. It has increased from 6.63 (Mar 24) to 6.92, marking an increase of 0.29.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 5.95. This value exceeds the healthy maximum of 3. It has increased from 5.79 (Mar 24) to 5.95, marking an increase of 0.16.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness